Indonesia

in page functions
Total population (2013) 249,865,631
Birth cohort (2013) 4,690,597
Surviving Infants (surviving to 1 year per year, 2013) 4,572,370
Infant mortality rate (deaths < 1 year per 1000 births, 2012) 26/1000
Child mortality rate (deaths < 5 years per 1000 births, 2012) 31/1000
Gross Nation Income (per capita US$, 2012) 3,420
Co-financing status (2013) Graduating
No. of districts/territories (2012) 497

GAVI support for Indonesia

Type of support

Approvals

2001-2017 (US$)
(31 Dec 2013)

Commitments

2001-2017 (US$)
(31 Dec 2013)

Disbursements

2000-2013 (US$)
(31 Dec 2013)

% Disbursed

(31 Dec 2013)
2002 2003 2004 2005 2006 2007 2008 2011 2012 2013 2014 2015 2016
Civil Society Organisation support (CSO) $3,900,500 $3,900,500 $4,000,500 103%
Health system strengthening (HSS) $15,407,000 $24,827,500 $15,407,000 100%
HepB mono (NVS) $17,511,000 $17,511,000 $17,511,000 100%
Immunisation services support (ISS) $12,636,000 $12,636,000 $12,636,000 100%
Injection safety support (INS) $9,856,844 $9,856,844 $9,856,844 100%
Penta (NVS) $30,477,500 $51,176,500 $30,477,500 100%
Vaccine Introduction Grant $3,891,000 $3,891,000 $3,891,000 100%
Total $93,679,844 $123,799,344 $93,779,844

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the GAVI Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Indonesia DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2012)

Grade of confidence
64%

*
DTP3 - Official country estimates (2012) 73%
M:F sex ratio at birth (2013) 1.05
Household survey: DTP3 coverage for male (2011) 73.10%
Household survey: DTP3 coverage for female (2011) 70.90%
Household survey: Last DTP3 survey (2011) 72%
% districts achieving > 80% DTP3 coverage (2012) 79%
% districts achieving < 50% DTP3 coverage (2012) 4%
MCV WHO/UNICEF estimates (2012) 80%
Polio WHO/UNICEF estimates (2012) 69%

Breakdown of support

Non-vaccine support Vaccine support
49% 51%
$45,791,343 $47,988,500

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Indonesia

21 August 2013

Bio Farma pentavalent vaccine

Indonesia introduces five-in-one vaccine for children

Children across Indonesia are set to be protected from five major childhood diseases through the pentavalent vaccine thanks to an ambitious plan to reach children across the country’s 6,000 inhabited islands by the end of next year.

07 August 2013

Sabin Institute

At Dakar conference, countries showcase increased efforts to fund their own immunisation programs

Sabin Vaccine Institute convenes government officials to discuss progress on sustainable immunization financing programs (News release: Sabin Vaccine Institute).

18 April 2013

Pentavalent infographic preview

Indian manufacturer cuts price of childhood vaccine by 30 percent

The cost of immunising millions of the world’s most vulnerable children against five deadly and debilitating diseases is set to fall, thanks to a major price reduction of one third for pentavalent vaccine. This new, more cost-effective price provides the opportunity for the GAVI Alliance to pay up to US$ 150 million less over the next four years compared with using lowest cost alternative suppliers.

close icon

modal window here